These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11320498

  • 1. Adsorption of natriuretic factors in uremia.
    Franz M, Woloszczuk W, Hörl WH.
    Semin Nephrol; 2001 May; 21(3):298-302. PubMed ID: 11320498
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Clinical relevance of cardiac natriuretic peptides measured by means of competitive and non-competitive immunoassay methods in patients with renal failure on chronic hemodialysis.
    Clerico A, Caprioli R, Del Ry S, Giannessi D.
    J Endocrinol Invest; 2001 Jan; 24(1):24-30. PubMed ID: 11227728
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Modification of atrial natriuretic peptide (ANP) and cyclic GMP by hemofiltration and hemodialysis].
    Eisenhauer T, Talartschik J, Quentin E, Kreutzfeldt W, Scheler F.
    Klin Wochenschr; 1988 Sep 15; 66(18):940-5. PubMed ID: 2846948
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases.
    Franz M, Woloszczuk W, Hörl WH.
    Kidney Int; 2001 May 15; 59(5):1928-34. PubMed ID: 11318965
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of sham hemodialysis on plasma levels of vasoactive peptides in patients with uremia.
    Hegbrant J, Mårtensson L, Thysell H, Ekman R, Boberg U.
    ASAIO J; 1992 May 15; 38(3):M197-200. PubMed ID: 1281014
    [Abstract] [Full Text] [Related]

  • 18. Renal dysfunction is a confounder for plasma natriuretic peptides in detecting heart dysfunction in uremic and idiopathic dilated cardiomyopathies.
    Codognotto M, Piccoli A, Zaninotto M, Mion M, Plebani M, Vertolli U, Tona F, Ruzza L, Barchita A, Boffa GM.
    Clin Chem; 2007 Dec 15; 53(12):2097-104. PubMed ID: 17934072
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Atrial natriuretic peptide vs. N-terminal-pro-atrial natriuretic peptide for the detection of left atrial dilatation in horses.
    van der Vekens N, Decloedt A, de Clercq D, Ven S, Sys S, van Loon G.
    Equine Vet J; 2016 Jan 15; 48(1):15-20. PubMed ID: 25257480
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.